Season 2018
ENP5: Disorders in Childhood Cancer Survivors
ENP3: Semen Quality and General Male Health
ENP2: Autoimmune Diabetes Outcomes and Anti-Cancer Agents
We interview Charles Sklar, from Memorial Sloan-Kettering Cancer Center, about the latest Endocrine Society clinical practice guideline. Dr. Sklar talks about the need to screen for endocrine disorders in long-term survivors of childhood cancer. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.
We talk with Alberto Ferlin, a professor of endocrinology at the University of Brescia, Italy, about his cohort findings connecting semen quality, reproductive function, and conditions in men such as hypogonadism, high body-mass index, and metabolic syndrome. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.
We talk about diabetes and cancer with Anupam Kotwal, endocrinology fellow at the Mayo Clinic. His research shows the potential for autoimmune diabetes outcomes from novel anti-cancer agents. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.
We talk with Stephanie Page, a professor of medicine at the University of Washington, about research on what she calls a prototype male pill. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.